|

Doxil Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Liposomal doxorubicin, doxorubicin hydrochloride liposome injection

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Sham Sunder Kakar1
  • SCRI Development Innovations, LLC1

Indications

  • Cancer2
  • Recurrent Ovarian Cancer1
  • Breast Cancer1

Louisville, Kentucky1 trial

Combination Therapy for Recurrent Ovarian Cancer

UofL Health Brown Cancer Center

Phase 1/2

Columbia, Maryland1 trial

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Maryland Oncology Hematology

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.